nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adherence to postoperative thromboprophylactic medication among gynecologic oncology patients: A subanalysis
|
Ross, Megan E. |
|
|
158 |
3 |
p. 754-759 |
artikel |
2 |
A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology
|
Chambers, Laura M. |
|
|
158 |
3 |
p. 794-802 |
artikel |
3 |
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative
|
Straubhar, Alli M. |
|
|
158 |
3 |
p. 608-613 |
artikel |
4 |
A multivariate analysis of the prognostic impact of tumor burden, surgical timing and complexity after complete cytoreduction for advanced ovarian cancer
|
Angeles, Martina Aida |
|
|
158 |
3 |
p. 614-621 |
artikel |
5 |
Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study
|
Bernard, Laurence |
|
|
158 |
3 |
p. 597-602 |
artikel |
6 |
Corrigendum to ‘Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma’ [Gynecologic Oncology 155 (2019) 499–507]
|
Zhou, Jian-Guo |
|
|
158 |
3 |
p. 812 |
artikel |
7 |
Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma
|
Bonazzoli, Elena |
|
|
158 |
3 |
p. 769-775 |
artikel |
8 |
Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging
|
Balaya, V. |
|
|
158 |
3 |
p. 576-583 |
artikel |
9 |
Does timing of intraperitoneal chemotherapy initiation following primary cytoreductive surgery with bowel resection impact outcomes in patients with advanced ovarian cancer?
|
Nica, Andra |
|
|
158 |
3 |
p. 622-630 |
artikel |
10 |
Editorial board
|
|
|
|
158 |
3 |
p. xii |
artikel |
11 |
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach
|
Marchetti, Claudia |
|
|
158 |
3 |
p. 740-746 |
artikel |
12 |
Following chemotherapy for gestational trophoblastic neoplasia, do residual lung lesions increase the risk of relapse?
|
Bouchard-Fortier, Genevieve |
|
|
158 |
3 |
p. 698-701 |
artikel |
13 |
Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer
|
Narasimhulu, Deepa Maheswari |
|
|
158 |
3 |
p. 646-652 |
artikel |
14 |
Genomic characterization of vulvar squamous cell carcinoma
|
Prieske, Katharina |
|
|
158 |
3 |
p. 547-554 |
artikel |
15 |
Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions
|
Simms, Kate T. |
|
|
158 |
3 |
p. 710-718 |
artikel |
16 |
Immune checkpoint inhibitors in women with gynecologic cancers: Practical considerations
|
Kurnit, Katherine C. |
|
|
158 |
3 |
p. 531-537 |
artikel |
17 |
Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction
|
Lago, V. |
|
|
158 |
3 |
p. 603-607 |
artikel |
18 |
Insomnia and its association with quality of life in women with ovarian cancer
|
Ross, Tanya L. |
|
|
158 |
3 |
p. 760-768 |
artikel |
19 |
Long term follow-up of a large series of stage-II/III atypical proliferative serous ovarian tumors
|
Maria, Sophie |
|
|
158 |
3 |
p. 659-665 |
artikel |
20 |
Long-term survival in obese patients after robotic or open surgery for endometrial cancer
|
Lindfors, Anna |
|
|
158 |
3 |
p. 673-680 |
artikel |
21 |
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival
|
Brieger, Katharine K. |
|
|
158 |
3 |
p. 702-709 |
artikel |
22 |
Molecular characterization of vulvar squamous cell cancer: High time to gain ground
|
Zeimet, Alain G. |
|
|
158 |
3 |
p. 519-520 |
artikel |
23 |
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network
|
Derquin, F. |
|
|
158 |
3 |
p. 666-672 |
artikel |
24 |
Nomograms based on the novel platelet index score predict postoperative prognosis in endometrial cancer
|
Chen, Hao |
|
|
158 |
3 |
p. 689-697 |
artikel |
25 |
Perioperative outcomes of women with and without class III obesity undergoing hysterectomy for endometrioid endometrial cancer: A population-based study
|
Simpson, A.N. |
|
|
158 |
3 |
p. 681-688 |
artikel |
26 |
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer
|
Moore, Kathleen N. |
|
|
158 |
3 |
p. 631-639 |
artikel |
27 |
Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study
|
Huh, Warner K. |
|
|
158 |
3 |
p. 562-569 |
artikel |
28 |
Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract
|
Frumovitz, Michael |
|
|
158 |
3 |
p. 570-575 |
artikel |
29 |
Physical activity and exercise in women with ovarian cancer: A systematic review
|
Jones, Tamara L. |
|
|
158 |
3 |
p. 803-811 |
artikel |
30 |
PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer
|
Martell, Kevin |
|
|
158 |
3 |
p. 776-784 |
artikel |
31 |
Principles of ethics and critical communication during the COVID-19 pandemic
|
Shalowitz, David I. |
|
|
158 |
3 |
p. 526-530 |
artikel |
32 |
Prospective cohort study of metabolic syndrome and endometrial cancer survival
|
Kokts-Porietis, Renée L. |
|
|
158 |
3 |
p. 727-733 |
artikel |
33 |
Risk of second primary cancers among survivors of gynecological cancers
|
Adjei Boakye, Eric |
|
|
158 |
3 |
p. 719-726 |
artikel |
34 |
Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening
|
Ara, Rifat |
|
|
158 |
3 |
p. 590-596 |
artikel |
35 |
Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Comprehensive management of a newly diagnosed young adult
|
Pressey, Joseph G. |
|
|
158 |
3 |
p. 538-546 |
artikel |
36 |
Social needs in gynecologic oncology: A Society of Gynecologic Oncology (SGO) clinical practice statement
|
Esselen, K. |
|
|
158 |
3 |
p. 521-525 |
artikel |
37 |
Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study
|
Hamilton, Erika |
|
|
158 |
3 |
p. 640-645 |
artikel |
38 |
The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance
|
Cobb, Lauren P. |
|
|
158 |
3 |
p. 653-658 |
artikel |
39 |
Time trends in the incidence and survival of vaginal squamous cell carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark – A nationwide population-based study
|
Bertoli, Hanna Kristina |
|
|
158 |
3 |
p. 734-739 |
artikel |
40 |
Transcriptomic and immunohistochemical approaches identify HLA-G as a predictive biomarker of gestational choriocarcinoma resistance to monochemotherapy
|
Bolze, Pierre-Adrien |
|
|
158 |
3 |
p. 785-793 |
artikel |
41 |
Tumor-free margins and local recurrence in squamous cell carcinoma of the vulva
|
Yang, Jie |
|
|
158 |
3 |
p. 555-561 |
artikel |
42 |
Value of endocervical curettage in follow-up for patients with cervical intraepithelial neoplasia stage 2+ after loop electrosurgical excision
|
Cao, Dan |
|
|
158 |
3 |
p. 584-589 |
artikel |
43 |
Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system
|
McCuaig, Jeanna M. |
|
|
158 |
3 |
p. 747-753 |
artikel |